Effective Knowledge Management in Translational Medicine

Overview

Journal J Transl Med

Publisher Biomed Central

Specialties Biomedical Engineering
General Medicine

Date 2010 Jul 21

PMID 20642836

Citations 42

Authors

Sandor Szalma

Venkata Koka

Tatiana Khasanova

Eric D Perakslis

Affiliations

Soon will be listed here.

Abstract

Background: The growing consensus that most valuable data source for biomedical discoveries is derived from human samples is clearly reflected in the growing number of translational medicine and translational sciences departments across pharma as well as academic and government supported initiatives such as Clinical and Translational Science Awards (CTSA) in the US and the Seventh Framework Programme (FP7) of EU with emphasis on translating research for human health.

Methods: The pharmaceutical companies of Johnson and Johnson have established translational and biomarker departments and implemented an effective knowledge management framework including building a data warehouse and the associated data mining applications. The implemented resource is built from open source systems such as i2b2 and GenePattern.

Results: The system has been deployed across multiple therapeutic areas within the pharmaceutical companies of Johnson and Johnsons and being used actively to integrate and mine internal and public data to support drug discovery and development decisions such as indication selection and trial design in a translational medicine setting. Our results show that the established system allows scientist to quickly re-validate hypotheses or generate new ones with the use of an intuitive graphical interface.

Conclusions: The implemented resource can serve as the basis of precompetitive sharing and mining of studies involving samples from human subjects thus enhancing our understanding of human biology and pathophysiology and ultimately leading to more effective treatment of diseases which represent unmet medical needs.

Citing Articles

Artificial intelligence-driven translational medicine: a machine learning framework for predicting disease outcomes and optimizing patient-centric care.

Abualigah L, Alomari S, Almomani M, Zitar R, Saleem K, Migdady H J Transl Med. 2025; 23(1):302.

PMID: 40065389 PMC: 11892274. DOI: 10.1186/s12967-025-06308-6.

Semantic Harmonization of Alzheimer's Disease Datasets Using AD-Mapper.

Wegner P, Balabin H, Ay M, Bauermeister S, Killin L, Gallacher J J Alzheimers Dis. 2024; 99(4):1409-1423.

PMID: 38759012 PMC: 11191441. DOI: 10.3233/JAD-240116.

Health data space nodes for privacy-preserving linkage of medical data to support collaborative secondary analyses.

Baumgartner M, Kreiner K, Lauschensky A, Jammerbund B, Donsa K, Hayn D Front Med (Lausanne). 2024; 11:1301660.

PMID: 38660421 PMC: 11039786. DOI: 10.3389/fmed.2024.1301660.

The European medical information framework: A novel ecosystem for sharing healthcare data across Europe.

Lovestone S Learn Health Syst. 2020; 4(2):e10214.

PMID: 32313838 PMC: 7156868. DOI: 10.1002/lrh2.10214.

Mining multi-site clinical data to develop machine learning MRI biomarkers: application to neonatal hypoxic ischemic encephalopathy.

Weiss R, Bates S, Song Y, Zhang Y, Herzberg E, Chen Y J Transl Med. 2019; 17(1):385.

PMID: 31752923 PMC: 6873573. DOI: 10.1186/s12967-019-2119-5.

References

Edgar R, Domrachev M, Lash A . Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res. 2001; 30(1):207-10. PMC: 99122. DOI: 10.1093/nar/30.1.207. View

Bild A, Yao G, Chang J, Wang Q, Potti A, Chasse D . Oncogenic pathway signatures in human cancers as a guide to targeted therapies. Nature. 2005; 439(7074):353-7. DOI: 10.1038/nature04296. View

Reich M, Liefeld T, Gould J, Lerner J, Tamayo P, Mesirov J . GenePattern 2.0. Nat Genet. 2006; 38(5):500-1. DOI: 10.1038/ng0506-500. View

Rhodes D, Kalyana-Sundaram S, Mahavisno V, Varambally R, Yu J, Briggs B . Oncomine 3.0: genes, pathways, and networks in a collection of 18,000 cancer gene expression profiles. Neoplasia. 2007; 9(2):166-80. PMC: 1813932. DOI: 10.1593/neo.07112. View

Hubble J, Demeter J, Jin H, Mao M, Nitzberg M, Reddy T . Implementation of GenePattern within the Stanford Microarray Database. Nucleic Acids Res. 2008; 37(Database issue):D898-901. PMC: 2686537. DOI: 10.1093/nar/gkn786. View

Riker A, Enkemann S, Fodstad O, Liu S, Ren S, Morris C . The gene expression profiles of primary and metastatic melanoma yields a transition point of tumor progression and metastasis. BMC Med Genomics. 2008; 1:13. PMC: 2408576. DOI: 10.1186/1755-8794-1-13. View

Nakamura Y, Suzuki T, Arai Y, Sasano H . 17beta-hydroxysteroid dehydrogenase type 11 (Pan1b) expression in human prostate cancer. Neoplasma. 2009; 56(4):317-20. DOI: 10.4149/neo_2009_04_317. View

Rhodes D, Yu J, Shanker K, Deshpande N, Varambally R, Ghosh D . Large-scale meta-analysis of cancer microarray data identifies common transcriptional profiles of neoplastic transformation and progression. Proc Natl Acad Sci U S A. 2004; 101(25):9309-14. PMC: 438973. DOI: 10.1073/pnas.0401994101. View

Dudley J, Tibshirani R, Deshpande T, Butte A . Disease signatures are robust across tissues and experiments. Mol Syst Biol. 2009; 5:307. PMC: 2758720. DOI: 10.1038/msb.2009.66. View

10.

Parkinson H, Kapushesky M, Kolesnikov N, Rustici G, Shojatalab M, Abeygunawardena N . ArrayExpress update--from an archive of functional genomics experiments to the atlas of gene expression. Nucleic Acids Res. 2008; 37(Database issue):D868-72. PMC: 2686529. DOI: 10.1093/nar/gkn889. View

11.

Barrett J, Fry B, Maller J, Daly M . Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics. 2004; 21(2):263-5. DOI: 10.1093/bioinformatics/bth457. View

12.

Murphy S, Mendis M, Hackett K, Kuttan R, Pan W, Phillips L . Architecture of the open-source clinical research chart from Informatics for Integrating Biology and the Bedside. AMIA Annu Symp Proc. 2008; :548-52. PMC: 2655844. View

13.

Karim R, Li W, Sanki A, Colman M, Yang Y, Thompson J . Reduced p16 and increased cyclin D1 and pRb expression are correlated with progression in cutaneous melanocytic tumors. Int J Surg Pathol. 2009; 17(5):361-7. DOI: 10.1177/1066896909336177. View

14.

Gould J, Getz G, Monti S, Reich M, Mesirov J . Comparative gene marker selection suite. Bioinformatics. 2006; 22(15):1924-5. DOI: 10.1093/bioinformatics/btl196. View

15.

Lamb J, Crawford E, Peck D, Modell J, Blat I, Wrobel M . The Connectivity Map: using gene-expression signatures to connect small molecules, genes, and disease. Science. 2006; 313(5795):1929-35. DOI: 10.1126/science.1132939. View

16.

Perakslis E, van Dam J, Szalma S . How informatics can potentiate precompetitive open-source collaboration to jump-start drug discovery and development. Clin Pharmacol Ther. 2010; 87(5):614-6. DOI: 10.1038/clpt.2010.21. View

17.

Chen R, Mallelwar R, Thosar A, Venkatasubrahmanyam S, Butte A . GeneChaser: identifying all biological and clinical conditions in which genes of interest are differentially expressed. BMC Bioinformatics. 2008; 9:548. PMC: 2629779. DOI: 10.1186/1471-2105-9-548. View

18.

Saltz J, Oster S, Hastings S, Langella S, Kurc T, Sanchez W . caGrid: design and implementation of the core architecture of the cancer biomedical informatics grid. Bioinformatics. 2006; 22(15):1910-6. DOI: 10.1093/bioinformatics/btl272. View

19.

Irgon J, Huang C, Zhang Y, Talantov D, Bhanot G, Szalma S . Robust multi-tissue gene panel for cancer detection. BMC Cancer. 2010; 10:319. PMC: 2906482. DOI: 10.1186/1471-2407-10-319. View